NewsWorldCovid: the five promising treatments administered or under study...

Covid: the five promising treatments administered or under study around the world – Sortaparis

-

By Laurent P. Posted on August 26, 2021 at 2:41 p.m.

As the vaccination against Covid progresses in France, with more than 75% of people having received a complete vaccination schedule, the search for a treatment continues, in particular to protect people who cannot be vaccinated for health reasons (or not receptive). We take stock of the five treatments particularly scrutinized by the French and European health authorities.

Monoclonal antibodies, polyclonal, antivirals… The treatments against the Covid, currently under study or already administered, arouse the curiosity and questioning of researchers, in the hope of finding a remedy, preventive or not, to help eradicate the virus in the world.

A research which is scrutinized with a certain attention by the French and European health authorities, with a view to supplementing the vaccine arsenal and allowing people who cannot receive the vaccine to still protect themselves against the disease.

In total, five treatments are currently under the watchful eye of regulators:

Coronavirus and Chloroquine: Professor Raoult's IHU Coronavirus and Chloroquine: Professor Raoult's IHU Coronavirus and Chloroquine: Professor Raoult's IHU Covid: molnupiravir, Merck’s promising treatment in phase 3 clinical trial
Good news in the fight against Covid! The Merck and Ridgeback Bio laboratories announced last April to have had promising results for a treatment against the virus, molnupiravir, which would significantly reduce the viral load of patients. An orally administered drug, the results of which from a phase 3 clinical trial are expected in September or October 2021. [Lire la suite]

Coronavirus: a former Nobel Prize winner in medicine thinks he came out of a laboratoryCoronavirus: a former Nobel Prize winner in medicine thinks he came out of a laboratoryCoronavirus: a former Nobel Prize winner in medicine thinks he came out of a laboratoryCoronavirus: a former Nobel Prize winner in medicine thinks he came out of a laboratoryCovid: Ronapreve, the preventive treatment authorized by the HAS for immunocompromised people
Immunosuppressed people, less protected against the coronavirus, will be authorized to receive preventive treatment against Covid-19, based on monoclonal antibodies, announced the High Authority for Health. [Lire la suite]

Covid: Xav-19, the antibody treatment made in France undergoing clinical trialCovid: Xav-19, the antibody treatment made in France undergoing clinical trialCovid: Xav-19, the antibody treatment made in France undergoing clinical trialCovid: Xav-19, the antibody treatment made in France undergoing clinical trialCovid: update on Xav-19, antibody treatment made in France undergoing clinical trial
What if, in the fight against Covid, we could count, in addition to the future vaccine, on antibody treatments? After Bamlanivimab, the treatment developed by the Eli Lilly laboratory, or even Regeneron, it is the turn of a French laboratory located in Nantes, Xenothera, to present its product undergoing clinical trial, Xav-19. A treatment which has just entered phase 3 of a clinical trial, for possible commercialization in the fall of 2021. [Lire la suite]

Covid: interferons, monoclonal antibodies ... What treatments are popular with Véran?Covid: interferons, monoclonal antibodies ... What treatments are popular with Véran?Covid: interferons, monoclonal antibodies ... What treatments are popular with Véran?Covid: interferons, monoclonal antibodies ... What treatments are popular with Véran?Covid – AstraZeneca: first promising results for preventive antibody treatment
The AstraZeneca laboratory unveiled on Friday August 20 the first promising results of a study on a preventive treatment of Covid by antibodies. A treatment that would reduce the risk of developing a severe form of the disease by 77%. We take stock! [Lire la suite]

Covid: RoActemra, an anti-inflammatory drug as a treatment under study by the EMACovid: RoActemra, an anti-inflammatory drug as a treatment under study by the EMACovid: RoActemra, an anti-inflammatory drug as a treatment under study by the EMACovid: RoActemra, an anti-inflammatory drug as a treatment under study by the EMACovid: RoActemra (Tocilizumab) as treatment under study by EMA
Tocilizumab, a treatment against Covid still under study? The European Medicines Agency has announced that it is testing hospitalized patients with RoActemra (Tocilizumab), an anti-inflammatory drug, in severe cases. A treatment capable of blocking the action of interleukin-6 and avoiding cytokine shocks, excess inflammation of the lungs. [Lire la suite]

1 COMMENT

Comments are closed.

Latest news

“Mbappé will be at PSG next season”: the story behind Karl Olive’s astonishing tweet – archyde

Ordinarily, Karl Olive masters the art of communication rather well. The former journalist and sports boss of Canal...

Erdogan has a “bazaar trader’s mentality.” Finns and Swedes will join NATO in exchange for three things – Denník N

They are incubators of terrorism. This is how Turkish President Recep Tayyip Erdogan called Sweden and Finland, threatening...

Galli: “I don’t expect cholera epidemic, more typhus risk”

On the WHO's alarm about the risk of cholera outbreaks in Mariupol in Ukraine, "I think that typhus is...

Ukraine, Moscow expels 24 Italian diplomats

(Adnkronos) - Diplomatic sources tell Adnkronos

US soccer reaches agreement on equal pay for men and women

SYDNEY, AUSTRALIA - NOVEMBER 27: The United States celebrate after defeating the Matildas during the first match of the...

You might also likeRELATED
Recommended to you